Hanano Mamada

Observational study of financial and non-financial conflicts of interest among the Japanese government advisory board members concerning coronavirus disease 2019

T. Sawano, T. Tanimoto, D. Bhandari, 2023, Medicine.

Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019

Akihiko Ozaki, T. Sawano, T. Tanimoto, 2022, medRxiv.

Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019

T. Sawano, T. Tanimoto, D. Bhandari, 2022, Respiration.

Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan

Akihiko Ozaki, T. Tanimoto, A. Murayama, 2021, Clinical Microbiology and Infection.

Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd.

T. Tanimoto, A. Murayama, H. Saito, 2023, Cost Effectiveness and Resource Allocation.

Financial Relationships Between Pharmaceutical Companies and Rheumatologists in Japan Between 2016 and 2019

T. Tanimoto, A. Murayama, H. Saito, 2022, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors’ Self‐Citation Rate in Japan and the United States

Akihiko Ozaki, T. Sawano, M. Vassar, 2022, Arthritis care & research.